Company Information
About the Company:
Babel is an award-winning contemporary theatre company creating multidisciplinary, highly-visual theatre which integrates movement, text and music to communicate the grey areas in life where language alone is insufficient. We strive to make our work wide open to interpretation and put our audience at the heart of the narrative.
We believe in creating a sense of TOTAL THEATRE, where all elements of a production are artistically integral. Immersing our audiences in a world of sound and colours and unpacking vital, visceral emotions and ideas that resonate with contemporary living, placing our audiences and their experiences at the centre of the play.
Company Website:
Listing Information
Location:
London, UK
Opportunity Description:
🧨 Bursary Announcement for Black and Brown Artists ⚡️
Thanks to some of our previous participants who opted to pay a little extra in advocacy and allyship, we can offer two fully funded places on the August INFUSE Residency.
We have 2 fully funded bursary places available and 10 regular spaces left available - All of these are dedicated to Black and Brown Artists.
50% of places on the residency are dedicated to Black and Brown Artists. The INFUSE Bursary is specifically for Black and Brown artists who wish to develop their practice and is fully funded by previous participants who chose to pay a little extra. The Bursary is targeted at people who can demonstrate why this would be a pivotal experience for them at this moment. Artists from any discipline are welcome to apply. Everyone who applies will receive a response.
MOVEMENT, CREATION AND PERFORMANCE
INFUSE your practice, joining the incredible Rhys Denn in a week-long deep dive developing movement, creation and exploring performance .
An uplifting and collaborative week of movement language, and exciting new ideas for developing performance.
Type of Work:
Rates/Compensation + Hours of Work/Dates:
Paid bursary place for INFUSE Residency (valued at £250)
How to Apply:
Applications will be reviewed on a rolling basis.
Other Details:
Deadline:
July 19, 2024